Acasti Pharma (ACST) Stock Chart & Stock Price History → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free ACST Stock Alerts $3.45 +0.05 (+1.47%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Acasti Pharma Stock Price Performance5 Day Performance+1.47%1 Month Performance+3.29%3 Month Performance+19.38%6 Month Performance+25.91%Year-To-Date Performance+19.38%1 Year Performance+32.49% Receive ACST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… ACST Stock Chart for Friday, March, 29, 2024 ACST Chart by TradingView Acasti Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024$3.40$3.45+1.47%$3.45$3.3733,131 shs$32.43 million03/27/2024$3.40$3.40$3.44$3.37224,147 shs$31.96 million03/26/2024$3.41$3.40-0.29%$3.44$3.3722,567 shs$31.96 million03/25/2024$3.40$3.41+0.29%$3.42$3.3817,025 shs$32.05 million03/22/2024$3.42$3.41-0.29%$3.42$3.3819,686 shs$32.05 million03/21/2024$3.40$3.42+0.59%$3.45$3.3730,588 shs$32.15 million Get the Latest News and Ratings for ACST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024$3.40$3.40$3.40$3.3317,518 shs$31.96 million03/19/2024$3.40$3.40$3.41$3.3423,872 shs$31.96 million03/18/2024$3.38$3.40+0.59%$3.41$3.3616,140 shs$31.96 million03/15/2024$3.41$3.41$3.43$3.3611,977 shs$32.05 million03/14/2024$3.40$3.41+0.29%$3.45$3.3838,993 shs$32.05 million03/13/2024$3.43$3.40-0.87%$3.41$3.3318,481 shs$31.96 million03/12/2024$3.35$3.43+2.39%$3.45$3.3448,519 shs$32.24 million03/11/2024$3.40$3.35-1.47%$3.36$3.2624,876 shs$31.49 million03/08/2024$3.40$3.40$3.44$3.3015,310 shs$31.96 million03/07/2024$3.45$3.40-1.45%$3.45$3.3121,168 shs$31.96 million03/06/2024$3.40$3.45+1.47%$3.49$3.3416,848 shs$32.43 million03/05/2024$3.44$3.40-1.16%$3.46$3.3243,075 shs$31.96 million03/04/2024$3.44$3.44+0.15%$3.48$3.3930,890 shs$32.34 million03/01/2024$3.34$3.48+4.19%$3.48$3.3611,422 shs$32.71 million02/29/2024$3.40$3.34-1.76%$3.48$3.3015,003 shs$31.40 million02/28/2024$3.33$3.40+2.10%$3.48$3.309,566 shs$31.96 million02/27/2024$3.34$3.33-0.30%$3.40$3.3011,681 shs$31.30 million02/26/2024$3.35$3.34-0.30%$3.37$3.2317,896 shs$31.39 million02/23/2024$3.39$3.35-1.18%$3.49$3.3119,394 shs$31.49 million02/22/2024$3.34$3.39+1.50%$3.59$3.3436,661 shs$31.87 million02/21/2024$3.11$3.34+7.40%$3.35$3.0454,204 shs$31.40 million02/20/2024$3.30$3.11-5.76%$3.35$3.1063,113 shs$29.23 million02/19/2024$3.30$3.30$3.30$2.9962,600 shs$31.02 million02/16/2024$3.06$3.30+7.84%$3.30$2.9962,364 shs$31.02 million02/15/2024$2.64$3.06+15.91%$3.06$2.5989,703 shs$28.76 million02/14/2024$2.45$2.64+7.76%$2.80$2.5222,915 shs$24.82 million02/13/2024$2.61$2.45-6.13%$2.72$2.4241,826 shs$23.03 million02/12/2024$2.45$2.61+6.53%$2.80$2.4164,157 shs$24.53 million02/09/2024$2.45$2.50+2.04%$2.50$2.438,231 shs$23.50 million02/08/2024$2.36$2.45+3.81%$2.48$2.386,014 shs$23.03 million02/07/2024$2.33$2.36+1.29%$2.50$2.3418,443 shs$22.18 million02/06/2024$2.30$2.33+1.30%$2.38$2.296,087 shs$21.90 million02/05/2024$2.38$2.30-3.36%$2.42$2.2522,844 shs$21.62 million02/02/2024$2.45$2.38-2.86%$2.50$2.3621,385 shs$22.37 millionSHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.02/01/2024$2.52$2.45-2.78%$2.48$2.407,623 shs$23.03 million01/31/2024$2.53$2.52-0.40%$2.56$2.4113,733 shs$23.69 million01/30/2024$2.50$2.53+1.20%$2.54$2.369,534 shs$23.78 million01/29/2024$2.55$2.50-1.96%$2.52$2.428,506 shs$23.50 million01/26/2024$2.39$2.55+6.69%$2.55$2.394,138 shs$23.97 million01/25/2024$2.41$2.39-0.83%$2.47$2.314,111 shs$22.47 million01/24/2024$2.45$2.41-1.63%$2.50$2.3419,036 shs$22.65 million01/23/2024$2.43$2.45+0.82%$2.45$2.305,212 shs$23.03 million01/22/2024$2.44$2.43-0.41%$2.48$2.2719,055 shs$22.84 million01/19/2024$2.41$2.44+1.24%$2.47$2.2811,326 shs$22.94 million01/18/2024$2.18$2.41+10.55%$2.51$2.1967,403 shs$22.65 million01/17/2024$2.59$2.18-15.83%$2.56$1.9887,581 shs$20.49 million01/16/2024$2.68$2.59-3.36%$2.76$2.5222,502 shs$24.35 million01/15/2024$2.68$2.68$2.78$2.6313,200 shs$25.19 million01/12/2024$2.76$2.68-2.90%$2.78$2.6313,193 shs$25.19 million01/11/2024$2.84$2.76-2.82%$2.86$2.717,688 shs$25.94 million01/10/2024$2.86$2.84-0.53%$2.94$2.7427,603 shs$26.70 million01/09/2024$2.88$2.86-0.87%$2.95$2.749,945 shs$26.84 million01/08/2024$2.87$2.88+0.35%$3.14$2.7974,139 shs$27.07 million01/05/2024$2.71$2.87+5.90%$2.90$2.6549,199 shs$26.98 million01/04/2024$2.72$2.71-0.37%$2.72$2.657,572 shs$25.47 million01/03/2024$2.76$2.72-1.45%$2.78$2.659,637 shs$25.57 million01/02/2024$2.89$2.76-4.50%$2.93$2.758,919 shs$25.94 million01/01/2024$2.89$2.89$2.90$2.6028,500 shs$27.17 million12/29/2023$2.91$2.89-0.69%$2.90$2.6128,526 shs$27.17 million12/28/2023$3.05$2.91-4.59%$3.18$2.83105,627 shs$27.35 million Related Companies: EFTR Stock Price Chart BIOR Stock Price Chart NLTX Stock Price Chart SPRB Stock Price Chart SLS Stock Price Chart APM Stock Price Chart VYNE Stock Price Chart LIAN Stock Price Chart ACXP Stock Price Chart THTX Stock Price Chart Receive ACST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACST) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.